ENTITY

Lixte Biotechnology Holdings I (LIXT US)

Health CareUnited States
Lixte Biotechnology Holdings Inc. offers tests for the early detection of cancers. The Company focuses on developing new treatments for the primary brain cancer and glioblastoma multiforme ("GBM"). Lixte Biotechnology Holdings serves patients in the United States.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x